A groundbreaking study has identified an inherited gene mutation that significantly increases the risk of prostate cancer in families with a history ...
本文仅供中国大陆地区执业的医学药学专业人士参考,如您非前述专业人士,请离开本页面 本文仅供医疗卫生等专业人士参考审批码:TML0038594,有效期为 2025-01-21 至 2026-01-20,资料过期,视同作废内容策划:方程项目审核:于轩题图来源:图虫创意参考文献:[1]Fan Y, Zhou JY, Zhao Y, et al. Efficacy, safety, and ...
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...